Seres Therapeutics Inc. (MCRB)
NASDAQ: MCRB
· Real-Time Price · USD
16.70
-0.16 (-0.95%)
At close: Aug 15, 2025, 3:59 PM
16.08
-3.74%
After-hours: Aug 15, 2025, 07:58 PM EDT
Seres Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 85.97M | 72.95M | 136K | -25.48M | -162.1M | -82.68M | -113.72M | -141.27M | -153.42M | -264.71M | -250.16M | -231.36M | -103.14M | -86.74M | -65.58M | -33.83M | -132.33M | -104.71M |
Depreciation & Amortization | 4.62M | 4.99M | 5.47M | 8.44M | 8.72M | 8.82M | 8.66M | 6.24M | 6.3M | 6.46M | 6.63M | 6.55M | 6.3M | 6.04M | 5.95M | 5.9M | 5.99M | 6.25M |
Stock-Based Compensation | 14.11M | 17.3M | 20.97M | 22.29M | 25.78M | 33.74M | 34.1M | 36.31M | 34M | 27.25M | 25.48M | 23.86M | 23.35M | 21.68M | 20.22M | 17.25M | 13.65M | 10.49M |
Other Working Capital | -6.68M | -699K | 8.68M | 25.16M | 9.59M | 4.96M | -10.9M | -4.44M | -18.59M | -21.15M | -16.15M | -22.41M | -6.2M | -10.24M | -4.36M | 3.21M | -9.64M | -9.58M |
Other Non-Cash Items | -150.63M | -151.06M | -125.97M | -106.84M | 28.66M | 30.35M | 10.94M | -7.74M | 15.13M | 12.41M | 7.26M | 5.28M | 2.58M | 1.8M | 2.04M | 2.93M | 3.81M | 3.3M |
Deferred Income Tax | n/a | n/a | n/a | -21.17M | 199K | 1.64M | 1.64M | 22.81M | 1.44M | n/a | n/a | 429K | 945K | 1.68M | 2.53M | 2.1M | 1.58M | 851K |
Change in Working Capital | -16.05M | -32.69M | -30.13M | -15.39M | -63.97M | -48.79M | -58.98M | -39.09M | -26.65M | -20.73M | -18.39M | -32.91M | 29.28M | 25.29M | 41.53M | 46.27M | -5.68M | -15.04M |
Operating Cash Flow | -59.94M | -86.46M | -148.61M | -157.23M | -181.8M | -76.01M | -117.35M | -122.75M | -123.07M | -238.96M | -228.82M | -227.79M | -40.46M | -30.26M | 6.69M | 40.62M | -112.98M | -98.86M |
Capital Expenditures | -434K | -352K | -380K | -1.17M | -2.83M | -3.97M | -7.97M | -10.56M | -10.01M | -10.94M | -9.82M | -7.94M | -10.78M | -11.17M | -9.57M | -8.21M | -4.19M | -1.86M |
Cash Acquisitions | n/a | n/a | n/a | 6.81M | 6.81M | 6.81M | n/a | -16.19M | -16.19M | -16.19M | -9.39M | n/a | n/a | n/a | n/a | 19.9M | 19.9M | 19.9M |
Purchase of Investments | 13.52M | 13.52M | 13.52M | 13.52M | n/a | n/a | -4.43M | -16.51M | -16.51M | -24.49M | -48.22M | -65.77M | -80.17M | -77.18M | -95.97M | -158.63M | -257.3M | -252.3M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 11.75M | 22.98M | 44.45M | 85.83M | 107.63M | 140.47M | 162.64M | 164.87M | 186.16M | 169.63M | 143.16M | 102.04M | 65.09M |
Other Investing Acitivies | 127.76M | 129.16M | 129.16M | 122.35M | -5.41M | 4.94M | 11.75M | 27.94M | 69.32M | 83.13M | 92.25M | 83.61M | 71.44M | 45.13M | 9.81M | -10.84M | -150.62M | -132M |
Investing Cash Flow | 140.84M | 142.32M | 142.29M | 141.51M | -1.43M | 7.78M | 10.58M | 17.39M | 59.31M | 72.19M | 82.43M | 89.69M | 74.67M | 97.8M | 64.09M | -24.43M | -160.19M | -189.07M |
Debt Repayment | -127.91M | -127.91M | -127.91M | -127.91M | n/a | 50.52M | 50.52M | 50.52M | 50.52M | n/a | 25.7M | 25.7M | 25.7M | 25.7M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 13.83M | 13.83M | 14M | 14M | 1.8M | 9.46M | 10.52M | 13.95M | 10.53M | 3M | 2.73M | -1.64M | 940K | 1.4M | 1.01M | 3.94M | 35.54M | 34.97M |
Financial Cash Flow | -107.95M | -107.95M | -90.37M | -85.68M | 26.63M | 84.81M | 71.7M | 69.87M | 166.46M | 108.41M | 129.6M | 124.22M | 26.81M | 27.26M | 1.18M | 3.94M | 285.63M | 299.64M |
Net Cash Flow | -27.06M | -52.1M | -96.93M | -101.64M | -156.84M | 16.34M | -35.06M | -35.49M | 102.7M | -58.35M | -16.79M | -13.88M | 61.01M | 94.8M | 71.95M | 20.13M | 12.46M | 11.72M |
Free Cash Flow | -60.38M | -86.81M | -148.99M | -158.39M | -184.64M | -79.97M | -125.33M | -133.31M | -133.08M | -249.89M | -238.64M | -235.72M | -51.25M | -41.44M | -2.88M | 32.41M | -117.17M | -100.72M |